Clinical Trials

Find a Trial

Trial Summary

Protocol No.PHO-COG-FALLON-AHOD1331
StatusOPEN TO ACCRUAL
Principal InvestigatorPradhan, Kamnesh
ScopeNational
PhasePhase III
Age GroupChildren
TitleA Randomized Phase III Study of Brentuximab Vedotin (SGN-35, IND #117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents
Description
Key Eligibility
Applicable Disease SitesLymphoma, Hodgkin's (Child)
Participating InstitutionsIndiana University (IU)
  • IU Health North (For use by Cancer Center CTO only)
  • Riley Hospital for Children
Treatment TypeTreatment
ContactMelissa Lee, Phone: +1 317-944-4281
Pager: 312-1228
Email: mellee@iu.edu